chevron_leftBack
As of 24 April 2025, Vistin Pharma ASA has a market cap of $102.29M USD, ranking #20770 globally and #131 in Norway. It ranks #2068 in the Healthcare sector, and #471 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$102.29MUSD
1.06B NOK
Enterprise Value
$101.27MUSD
1.05B NOK
Revenue (TTM)
$41.28MUSD
429.5M NOK
EBITDA (TTM)
$10.03MUSD
104.33M NOK
Net Income (TTM)
$6.03MUSD
62.75M NOK
EBITDA Margin
24%
Profit Margin
15%
PE Ratio
17.0
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Magnus Tolleshaug
open_in_new
Employees
77
Founded
1969
Website
vistin.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 4.3% | 3.4% | -3.2% | 4.8% | -14% | -0.8% |
Upcoming Earnings
Earnings Date
Fri, Apr 25
Tomorrow
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
VISTN
ISIN: NO0010734122
Shares Out.:
Shares Outstanding:
44.345M1
Shares Float:
20.884M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
24.00 NOK | |
|
0RAM
ISIN: NO0010734122
|
23.00 NOK |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Vistin Pharma ASA
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
Country |
|---|---|---|
Photocure ASA
OSL: PHO
|
$139.11M
36%
1.45B NOK
|
